These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

703 related items for PubMed ID: 1975213

  • 1. Modulation of acetylcholine release by D1, D2 dopamine receptors in rat striatum under freely moving conditions.
    Ajima A, Yamaguchi T, Kato T.
    Brain Res; 1990 Jun 04; 518(1-2):193-8. PubMed ID: 1975213
    [Abstract] [Full Text] [Related]

  • 2. In vivo assessment of release and metabolism of dopamine in the ventrolateral striatum of awake rats following administration of dopamine D1 and D2 receptor agonists and antagonists.
    See RE, Sorg BA, Chapman MA, Kalivas PW.
    Neuropharmacology; 1991 Dec 04; 30(12A):1269-74. PubMed ID: 1686300
    [Abstract] [Full Text] [Related]

  • 3. Functional antagonism of D-1 and D-2 dopaminergic mechanisms affecting striatal acetylcholine release.
    Gorell JM, Czarnecki B, Hubbell S.
    Life Sci; 1986 Jun 16; 38(24):2247-54. PubMed ID: 2940433
    [Abstract] [Full Text] [Related]

  • 4. Regulation of dopamine D1 and D2 receptors on striatal acetylcholine release in rats.
    Ikarashi Y, Takahashi A, Ishimaru H, Arai T, Maruyama Y.
    Brain Res Bull; 1997 Jun 16; 43(1):107-15. PubMed ID: 9205804
    [Abstract] [Full Text] [Related]

  • 5. Pharmacological characterization of the receptor mediating electrophysiological responses to dopamine in the rat medial prefrontal cortex: a microiontophoretic study.
    Sesack SR, Bunney BS.
    J Pharmacol Exp Ther; 1989 Mar 16; 248(3):1323-33. PubMed ID: 2564893
    [Abstract] [Full Text] [Related]

  • 6. Pharmacologic evidence for direct dopaminergic regulation of striatal acetylcholine release.
    Gorell JM, Czarnecki B.
    Life Sci; 1986 Jun 16; 38(24):2239-46. PubMed ID: 2940432
    [Abstract] [Full Text] [Related]

  • 7. The regulation of dopamine release from nigrostriatal neurons in conscious rats: the role of somatodendritic autoreceptors.
    Santiago M, Westerink BH.
    Eur J Pharmacol; 1991 Oct 29; 204(1):79-85. PubMed ID: 1687125
    [Abstract] [Full Text] [Related]

  • 8. Dopamine depletion preferentially impairs D1- over D2-receptor regulation of striatal in vivo acetylcholine release.
    Bertorelli R, Zambelli M, Di Chiara G, Consolo S.
    J Neurochem; 1992 Jul 29; 59(1):353-7. PubMed ID: 1351928
    [Abstract] [Full Text] [Related]

  • 9. Modulation of in vivo dopamine release by D2 but not D1 receptor agonists and antagonists.
    Boyar WC, Altar CA.
    J Neurochem; 1987 Mar 29; 48(3):824-31. PubMed ID: 2949060
    [Abstract] [Full Text] [Related]

  • 10. Effect of dopamine D-1 and D-2 receptor selective drugs on dopamine release and metabolism in rat striatum in vivo.
    Zetterström T, Sharp T, Ungerstedt U.
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Oct 29; 334(2):117-24. PubMed ID: 2946964
    [Abstract] [Full Text] [Related]

  • 11. Dopamine stimulates growth hormone release from the pituitary of goldfish, Carassius auratus, through the dopamine D1 receptors.
    Wong AO, Chang JP, Peter RE.
    Endocrinology; 1992 Mar 29; 130(3):1201-10. PubMed ID: 1347006
    [Abstract] [Full Text] [Related]

  • 12. 5-HT2 receptor regulation of acetylcholine release induced by dopaminergic stimulation in rat striatal slices.
    Ramírez MJ, Cenarruzabeitia E, Lasheras B, Del Rio J.
    Brain Res; 1997 May 16; 757(1):17-23. PubMed ID: 9200494
    [Abstract] [Full Text] [Related]

  • 13. Dopamine receptor-mediated regulation of striatal cholinergic activity: positron emission tomography studies with norchloro[18F]fluoroepibatidine.
    Ding YS, Logan J, Bermel R, Garza V, Rice O, Fowler JS, Volkow ND.
    J Neurochem; 2000 Apr 16; 74(4):1514-21. PubMed ID: 10737608
    [Abstract] [Full Text] [Related]

  • 14. Supersensitization of intrastriatal dopamine receptors involved in opposite regulation of acetylcholine release in Parkinson's model rats.
    Sato K, Ueda H, Okumura F, Misu Y.
    Neurosci Lett; 1994 May 23; 173(1-2):59-62. PubMed ID: 7936424
    [Abstract] [Full Text] [Related]

  • 15. Physiological release of striatal acetylcholine in vivo: modulation by D1 and D2 dopamine receptor subtypes.
    DeBoer P, Abercrombie ED.
    J Pharmacol Exp Ther; 1996 May 23; 277(2):775-83. PubMed ID: 8627558
    [Abstract] [Full Text] [Related]

  • 16. The D1 agonist SKF 38393 increases dopamine release in the developing rat striatum.
    Walters DE, Howard SG.
    Eur J Pharmacol; 1990 Aug 10; 184(2-3):257-64. PubMed ID: 2150376
    [Abstract] [Full Text] [Related]

  • 17. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT, White FJ.
    Synapse; 1992 Mar 10; 10(3):206-16. PubMed ID: 1532677
    [Abstract] [Full Text] [Related]

  • 18. Dopaminergic modulation of cholinergic responses in rat medial prefrontal cortex: an electrophysiological study.
    Yang CR, Mogenson GJ.
    Brain Res; 1990 Aug 06; 524(2):271-81. PubMed ID: 1981327
    [Abstract] [Full Text] [Related]

  • 19. Differential actions of dopamine receptor subtypes on gonadotropin and growth hormone release in vitro in goldfish.
    Chang JP, Yu KL, Wong AO, Peter RE.
    Neuroendocrinology; 1990 Jun 06; 51(6):664-74. PubMed ID: 2141920
    [Abstract] [Full Text] [Related]

  • 20. Effects of D1 and D2 antagonists on the transient increase of dopamine release by dopamine agonists by means of brain dialysis.
    Kurata K, Shibata R.
    Neurosci Lett; 1991 Nov 25; 133(1):77-80. PubMed ID: 1686482
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.